Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs

A Ait-Ammar, A Kula, G Darcis, R Verdikt… - Frontiers in …, 2020 - frontiersin.org
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is
the “shock and kill” strategy which is based on HIV-1 reactivation in latently-infected cells …

HIV “shock and kill” therapy: In need of revision

E Abner, A Jordan - Antiviral research, 2019 - Elsevier
The implementation of antiretroviral therapy 23 years ago has rendered HIV infection
clinically manageable. However, the disease remains incurable, since it establishes latent …

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

W Yao, X Hu, X Wang - Signal Transduction and Targeted Therapy, 2024 - nature.com
Histone post-translational modifications (HPTMs), as one of the core mechanisms of
epigenetic regulation, are garnering increasing attention due to their close association with …

KAT5 acetylates cGAS to promote innate immune response to DNA virus

ZM Song, H Lin, XM Yi, W Guo… - Proceedings of the …, 2020 - National Acad Sciences
The DNA sensor cGMP-AMP synthase (cGAS) senses cytosolic microbial or self DNA to
initiate a MITA/STING-dependent innate immune response. cGAS is regulated by various …

Function and mechanism of novel histone posttranslational modifications in health and disease

H Xu, M Wu, X Ma, W Huang… - BioMed Research …, 2021 - Wiley Online Library
Histone posttranslational modifications (HPTMs) are crucial epigenetic mechanisms
regulating various biological events. Different types of HPTMs characterize and shape …

Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies

TM Ta, S Malik, EM Anderson, AD Jones… - Frontiers in …, 2022 - frontiersin.org
Although HIV-1 replication can be efficiently suppressed to undetectable levels in peripheral
blood by combination antiretroviral therapy (cART), lifelong medication is still required in …

New insights into transcription elongation control of HIV-1 latency and rebound

U Mbonye, F Kizito, J Karn - Trends in Immunology, 2023 - cell.com
Antiretroviral therapy reduces circulating HIV-1 to undetectable amounts but does not
eliminate the virus due to the persistence of a stable reservoir of latently infected cells. The …

Depicting HIV-1 transcriptional mechanisms: a summary of what we know

A Dutilleul, A Rodari, C Van Lint - Viruses, 2020 - mdpi.com
Despite the introduction of combinatory antiretroviral therapy (cART), HIV-1 infection cannot
be cured and is still one of the major health issues worldwide. Indeed, as soon as cART is …

Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV

Q Niu, Z Liu, E Alamer, X Fan, H Chen… - The Journal of …, 2019 - Am Soc Clin Investig
HIV integrates its provirus into the host genome and establishes latent infection.
Antiretroviral therapy (ART) can control HIV viremia, but cannot eradicate or cure the virus …

A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency

E Hsieh, DH Janssens, PJ Paddison, EP Browne… - PLoS …, 2023 - journals.plos.org
Transcriptional silencing of latent HIV-1 proviruses entails complex and overlap**
mechanisms that pose a major barrier to in vivo elimination of HIV-1. We developed a new …